APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL
Product details
Registration number: SIN17555P
Classification: Prescription Only
Active ingredients: Motixafortide acetate eqv Motixafortide
Strength: 62mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: SUBCUTANEOUS
Registrant: DCH AURIGA SINGAPORE
ATC code: L03AX23
HSA approval date: 8 June 2026
Manufacturer(s): BioConnection B.V.
Manufacturing country/countries: NETHERLANDS
What are the HSA registration number and classification for APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17555P
Classification: Prescription Only
What active ingredients and strength are recorded for APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Motixafortide acetate eqv Motixafortide
Strength: 62mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: DCH AURIGA SINGAPORE
Which manufacturers and countries are listed for APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): BioConnection B.V.
Manufacturing country/countries: NETHERLANDS
Where can I look up APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17555P or the exact product name APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL. The general register link does not preselect this product.
What are the source dates for this APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this APHEXDA LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION 62 MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17555P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)